Skip to main content

WELLS FARGO & COMPANY/MN

Position in RNAZ — Transcode Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in RNAZ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$341
-$132 QoQ
Shares Held
55
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 8 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNAZ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. RNAZ ranks #378 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RNAZ

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $341 55
2026-03-31 $473 55
2024-03-31 $3 5
2023-12-31 $25 155
2023-09-30 $5 11
2023-06-30 $9 4
2023-03-31 51
2022-12-31 $33 50
2022-09-30 49
2022-06-30 45
2022-03-31 41
2021-12-31 41
2021-09-30 38